Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Deena Victor
Phone: 713.441.4536
Brief Summary: To evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects with severe native aortic stenosis who are indicated for TAVR. Detailed Descripti ... Read more >
Status: Open Not Enrolling
Investigator: Neal Kleiman
Study Coordinator: Deena Victor
Phone: 713.441.4536
The primary objective of the study is to evaluate the safety and effectiveness of the Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk Pivotal Trial population due to one or more additional co-morbidi ... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Deena Victor
Phone: 713.441.4536
Brief Summary: To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surger ... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Deena Victor
Phone: 713.441.4536
Brief Summary: Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, symptomatic AS. Detailed Description: Multi-center, international, prospective, randomized ... Read more >
Status: Open Not Enrolling
Investigator: Neal Kleiman
Study Coordinator: Tia McGaughy
Phone: 346.238.4576
The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgic ... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Tia McGaughy
Phone: 346.238.4576
Brief Summary: Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device. Inclusion Criteria: Moderate to severe or severe symptomatic mitral regurgitation Loca ... Read more >